EATONTOWN, N.J., Aug. 16 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today reported new enrollment figures for its Medicare Special Needs Plans in New Jersey and South Dakota, including its SNP for dual eligible members. QMedCare of New Jersey added 55 new members to its SNP for the chronically ill in July, bringing total enrollees to 267 as of July 31st.
The Company's South Dakota SNP for the chronically ill added 122 in July, bringing total enrollment to 2770. In addition, the SNP for dual eligibles in the state added 106 new members since June for a total of 164. Both figures for total enrollment are as of July 31st.
Jane Murray, president and CEO, said, "We are pleased with the progress that these numbers show. They indicate that we are executing our plan and this gives us confidence in our marketing approach as well as for the outlook as we approach the open enrollment season. We anticipate continued growth through the rest of the year and going forward."
About QMed, Inc.
QMed provides evidence-based clinical information management systems around the country to its health plan customers. The system incorporates Disease Management services to patients and decision support to physicians. The Company's QMedCare subsidiary specializes in serving high-risk populations of Medicare beneficiaries. The Company also operates a Medicare Demonstration to test the feasibility of reimbursing its care coordinated DM services in the vast Medicare fee-for-service program. More information on QMed, Inc. can be obtained at http://www.qmedinc.com, by calling (732) 544-5544 or by emailing firstname.lastname@example.org.
Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of competitive product introductions, acceptance and pricing, and those risks detailed in the Company's filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.
|SOURCE QMed, Inc.|
Copyright©2007 PR Newswire.